Abstract
A master control of both the innate and adaptive immune system is the body’s ability to distinguish between self and foreign entities. This is accomplished by the elimination of autoreactive leukocytes through a series of checkpoints both in the thymus (central deletion) and in the circulating periphery (peripheral tolerance), thus establishing tolerance to self-antigens. When one or more of these controls is disrupted, there is the potential for the development of autoimmune disease. Current available therapies for these diseases often rely on global immune suppression or expensive treatments that are not affordable to all. Herein, we describe a novel therapeutic technique in which tolerance to self can be re-established via B-cell delivered antigen-specific tolerogenic gene constructs. Furthermore, this technique shows promise in the gene therapeutic treatment of monogenic disorders and the acceptance of tissue transplants.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Caspi RR (2008) Immunotherapy of autoimmunity and cancer: the penalty for success. Nat Rev Immunol 8:970–976
Scott DW (1994) The Nature of Immunologic Tolerance. R.G. Landes, Austin, TX
Billingham RE, Brent L, Medawar PB (1953) Actively acquired tolerance of foreign cells. Nature 172:603–606
Borel Y, Lewis RM, Stollar BD (1973) Prevention of murine lupus nephritis by carrier-dependent induction of immunologic tolerance to denatured DNA. Science 182:76–78
Borel Y (1980) Haptens bound to self IgG induce immunologic tolerance, while when coupled to syngeneic spleen cells they induce immune suppression. Immunol Rev 50:71–104
Lassila O, Vainio O, Matzinger P (1988) Can B cells turn on virgin T cells? Nature 334:253–255
Eynon EE, Parker DC (1992) Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J Exp Med 175:131–138
Fuchs EJ, Matzinger P (1992) B cells turn off virgin but not memory T cells. Science 258:1156–1159
Zambidis ET, Barth RK, Scott DW (1997) Both resting and activated B lymphocytes expressing engineered peptide-Ig molecules serve as highly efficient tolerogenic vehicles in immunocompetent adult recipients. J Immunol 158:2174–2182
Kang Y, Melo M, Deng E, Tisch R, El-Amine M, Scott DW (1999) Induction of hyporesponsiveness to intact foreign protein via retroviral-mediated gene expression: the IgG scaffold is important for induction and maintenance of immune hyporesponsiveness. Proc Natl Acad Sci U S A 96:8609–8614
Agarwal RK, Kang Y, Zambidis E, Scott DW, Chan CC, Caspi RR (2000) Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis. J Clin Invest 106:245–252
Liang W, Karabekian Z, Mattapallil M, Xu Q, Viley AM, Caspi R et al (2006) B-cell delivered gene transfer of human S-Ag-Ig fusion protein protects from experimental autoimmune uveitis. Clin Immunol 118:35–41
Xu B, Scott DW (2004) A novel retroviral gene therapy approach to inhibit specific antibody production and suppress experimental autoimmune encephalomyelitis induced by MOG and MBP. Clin Immunol 111:47–52
Xu B, Haviernik P, Wolfraim LA, Bunting KD, Scott DW (2006) Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAE. Mol Ther 13:42–48
Melo ME, Qian J, El-Amine M, Agarwal RK, Soukhareva N, Kang Y et al (2002) Gene transfer of Ig-fusion proteins into B cells prevents and treats autoimmune diseases. J Immunol 168:4788–4795
Soukhareva N, Jiang Y, Scott DW (2006) Treatment of diabetes in NOD mice by gene transfer of Ig-fusion proteins into B cells: role of T regulatory cells. Cell Immunol 240:41–46
Satpute SR, Soukhareva N, Scott DW, Moudgil KD (2007) Mycobacterial Hsp65-IgG-expressing tolerogenic B cells confer protection against adjuvant-induced arthritis in Lewis rats. Arthritis Rheum 56:1490–1496
Lei TC, Scott DW (2005) Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins. Blood 105:4865–4870
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this protocol
Cite this protocol
Rossi, R.J., Jackson, B.M., Zhang, AH., Scott, D.W. (2012). Tolerance Induction via B-Cell Delivered Gene Therapy. In: Perl, A. (eds) Autoimmunity. Methods in Molecular Biology, vol 900. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-720-4_23
Download citation
DOI: https://doi.org/10.1007/978-1-60761-720-4_23
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-719-8
Online ISBN: 978-1-60761-720-4
eBook Packages: Springer Protocols